pubmed-article:1665620 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1665620 | lifeskim:mentions | umls-concept:C0042776 | lld:lifeskim |
pubmed-article:1665620 | lifeskim:mentions | umls-concept:C0009450 | lld:lifeskim |
pubmed-article:1665620 | lifeskim:mentions | umls-concept:C0019348 | lld:lifeskim |
pubmed-article:1665620 | lifeskim:mentions | umls-concept:C0003242 | lld:lifeskim |
pubmed-article:1665620 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:1665620 | lifeskim:mentions | umls-concept:C1550587 | lld:lifeskim |
pubmed-article:1665620 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:1665620 | pubmed:dateCreated | 1992-4-8 | lld:pubmed |
pubmed-article:1665620 | pubmed:abstractText | Immunochemical study of blood sera from mice immunized with rabbit immunoglobulins (AT1) to herpes simplex virus type I (HSV-I) detected antiidiotypic antibodies AT2 in five of them (antiID). The affinity-purified antiID were shown to induce in syngeneic mice production of antibody (AT3) interacting with HSV-I antigen. In vitro, antiID (AT3) were shown to neutralize the virus activity. Analysis of the results suggests that the antiID imitate the antigenic properties of HSV-I and can induce specific immune response. | lld:pubmed |
pubmed-article:1665620 | pubmed:language | rus | lld:pubmed |
pubmed-article:1665620 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1665620 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1665620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1665620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1665620 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1665620 | pubmed:issn | 0507-4088 | lld:pubmed |
pubmed-article:1665620 | pubmed:author | pubmed-author:Barinski?I... | lld:pubmed |
pubmed-article:1665620 | pubmed:author | pubmed-author:KushchA AAA | lld:pubmed |
pubmed-article:1665620 | pubmed:author | pubmed-author:PosevaiaT ATA | lld:pubmed |
pubmed-article:1665620 | pubmed:author | pubmed-author:SimonovV IVI | lld:pubmed |
pubmed-article:1665620 | pubmed:author | pubmed-author:DaniliukO SOS | lld:pubmed |
pubmed-article:1665620 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1665620 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:1665620 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1665620 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1665620 | pubmed:pagination | 312-5 | lld:pubmed |
pubmed-article:1665620 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:meshHeading | pubmed-meshheading:1665620-... | lld:pubmed |
pubmed-article:1665620 | pubmed:articleTitle | [Anti-idiotypic antibodies to the herpes simplex type-1 virus neutralize the virus' infectious activity]. | lld:pubmed |
pubmed-article:1665620 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1665620 | pubmed:publicationType | English Abstract | lld:pubmed |